Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression clinical trials

Explore recruiting advanced metastatic castration resistant prostate cancer with prostate specific membrane antigen psma expression clinical trials.

Recruiting advanced metastatic castration resistant prostate cancer with prostate specific membrane antigen psma expression studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCRPC)

Belgium, Finland, Italy, Sweden, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression trials by city

Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Toronto Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Vancouver Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Montreal Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Calgary Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Edmonton Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Ottawa Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Winnipeg Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Quebec City Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Hamilton Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Kitchener Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in London Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Halifax Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in New York Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Los Angeles Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Chicago Advanced Metastatic Castration Resistant Prostate Cancer With Prostate Specific Membrane Antigen Psma Expression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease